Explore Veru's Q4 2025 earnings, strategic shift to drug development, regulatory clarity, and new trials for obesity management.
Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for ...
Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the ...
Weight loss drugs and cardiovascular health Presenter: Mitchell Steiner, Veru Inc.’s Chairman, President & CEO Session Date: December 12, 2025 Presentation Number: P3 Presentation Name: The Veru ...
TUCSON, AZ / ACCESS Newswire / December 8, 2025 / Umbrella Labs today announced the launch of its research-use-only MK-677 (Ibutamoren, Nutrobal) program, built around a liquid formulation and an ...
Investor attention is shifting toward a key scientific conference as shares of biotechnology firm Veru Inc. trade quietly. The company is scheduled to deliver multiple presentations on its lead drug ...
Josh Brett on MSN
Who’s really using SARMs - and why it’s becoming a problem
SARMs are exploding in popularity—but they’re not approved for human use. Marketed as “legal steroids,” they’re linked to ...
Most Popular Legal Steroids for Muscle Building from CrazyBulk: Best-Selling Steroid Alternatives for Lean Muscle Growth and ...
The expansion will add about one-third more active manufacturing space to Alnylam's production facility in Norton, and it is ...
The president of a local law enforcement group is sounding alarms about the reliability of cannabis products in Massachusetts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback